Asthma trials in United Kingdom

In United Kingdom 48 Also abroad 509

29 of 48 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Where
London
Age
6 years and over
People
230 worldwide
Run by
AstraZeneca
See details and how to joinNCT07444567
Phase 2Taking people
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
Where
London, Stoke-on-Trent
Age
6 years to 11 years
People
42 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05222529 · EU 2024-511382-11-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Where
Birmingham, Bradford, Bristol, Glasgow, Leicester, London, Nottingham, Stoke-on-Trent
Age
5 years to 11 years
People
231 worldwide
Run by
AstraZeneca
See details and how to joinNCT06023589
Phase 1Taking people
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Where
Manchester
Age
18 years to 65 years
People
84 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06433921 · EU 2024-511220-14-00
Phase 2Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Where
Bradford, Cambridge, Crumpsall, London, Manchester, Wakefield
Age
18 years to 75 years
People
252 worldwide
Run by
Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00
Phase 3Not yet taking people in United Kingdom
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Where
Oxford
Age
18 years to 79 years
People
150 worldwide
Run by
Université de Sherbrooke
See details and how to joinNCT07309614
Phase 3Taking people
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
Where
Great Cambourne, Greater Manchester
Age
18 years and over
People
110 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07645248
No phaseTaking people
Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)
Where
Cambridge
Age
18 years to 60 years
People
36
Run by
Akhilesh Jha
See details and how to joinNCT06488118
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Where
Ashburton, Bristol, High Wycombe, Honiton, London, Metropolitan Borough of Wirral, Nottingham, Plymouth, Romford, Rotherham, Sheffield, Somerton, Thetford
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07359846
Phase 1Taking people
Evaluation of Safety, Side Effects, and How the Drug, Inhaled CHF10136, Is Absorbed, Modified and Removed From the Body in Healthy Adults and Adults With Asthma
Where
Leeds, London, Manchester
Age
18 years to 65 years
People
120
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07851623
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Bedford, Birmingham, Bristol, Leicester, London, Wythenshawe
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
No phaseNot yet taking people in United Kingdom
Effectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation
Where
Leicester
Age
18 years and over
People
80
Run by
University of Leicester
See details and how to joinNCT07500948
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Bradford, Cambridge, Chertsey, Glasgow, London
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
No phaseTaking people
A Randomised Feasibility Study of CPAP in Large Airway Collapse
Where
Liverpool
Age
18 years and over
People
60
Run by
Liverpool School of Tropical Medicine
See details and how to joinNCT07504926
Phase 1/2Taking people
RIG 101 Trial in Healthy Adults and Adults With Asthma
Where
London, Manchester
Age
18 years to 65 years
People
82
Run by
RIGImmune Inc.
See details and how to joinNCT07488897
Phase 3Taking people
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Where
Bradford
Age
12 years and over
People
456 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00
No phaseTaking people
Physical Activity Promotion and Clinical Remission in Severe Asthma
Where
Leeds
Age
18 years to 70 years
People
140
Run by
University of Leeds
See details and how to joinNCT07735494
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Birmingham, Bradford, Leicester, London
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00
No phaseTaking people
The Barts Charity Children's Environmental Health Clinic
Where
London
Age
4 years to 17 years
People
200
Run by
Queen Mary University of London
See details and how to joinNCT06447974
No phaseTaking people
Investigating the Impact of Early Time-Restricted Eating on Health Outcomes and Quality of Life in Adults With Mild Controlled Asthma Compared to Healthy Adults
Where
Leicester
Age
18 years to 65 years
People
36
Run by
De Montfort University
See details and how to joinNCT07345572
Phase 3Taking people
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Where
Bradford, London, Southampton
Age
18 years and over
People
150 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00
Phase 2Taking people
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Where
Belfast, Bristol, Dagenham, London, Maidstone, Manchester, Orpington, Portsmouth, Romsey
Age
18 years to 75 years
People
780 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00
No phaseTaking people
Children's Health, Respiratory Inflammation and Short-term Air Pollution
Where
London
Age
7 years to 11 years
People
330
Run by
Queen Mary University of London
See details and how to joinNCT07431021
No phaseNot yet taking people in United Kingdom
Active Airways for Children and Young People With Asthma
Where
Leicester
Age
10 years to 17 years
People
60
Run by
University of Leicester
See details and how to joinNCT07643753
Phase 4Taking people
Dosing of Steroids for Acute Asthma Given in the Emergency Department - a Pilot Randomised Feasibility Trial of Dexamethasone in Children
Where
Sheffield
Age
4 years to 15 years
People
104
Run by
Sheffield Children's NHS Foundation Trust
See details and how to joinNCT07402707